Yang Z, Zhang X, Zhang J, Gao J, et al. Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT BMC Cancer 2022;22:462.
PMID: 35477432